Literature DB >> 22076819

Practical approach to screening for scleroderma-associated pulmonary arterial hypertension.

Aryeh Fischer1, Todd M Bull, Virginia D Steen.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22076819     DOI： 10.1002/acr.20693

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN： 2151-464X            Impact factor:   4.794


× No keyword cloud information.
  10 in total

1.  Is early diagnosis of pulmonary arterial hypertension possible in inflammatory rheumatic diseases? Experience from a single center in Turkey.

Authors:  Ali Akdoğan; Sercan Okutucu; Levent Kılıç; Barış Kaya; Banu Evranos; Kudret Aytemir; Lütfi Çöplü; İhsan Ertenli; Meral Çalgüneri; Ali Oto; Lale Tokgözoğlu
Journal:  Eur J Rheumatol       Date:  2015-03-01

2.  Latest advances in connective tissue disorders.

Authors:  Vijay Rao; Simon Bowman
Journal:  Ther Adv Musculoskelet Dis       Date:  2013-08       Impact factor: 5.346

3.  The frequency of pulmonary hypertension in patients with juvenile scleroderma.

Authors:  Amra Adrovic; Funda Oztunc; Kenan Barut; Aida Koka; Refet Gojak; Sezgin Sahin; Tuncalp Demir; Ozgur Kasapcopur
Journal:  Bosn J Basic Med Sci       Date:  2015-08-22       Impact factor: 3.363

4.  Changes in estimated right ventricular systolic pressure predict mortality and pulmonary hypertension in a cohort of scleroderma patients.

Authors:  Ami A Shah; Shang-En Chung; Fredrick M Wigley; Robert A Wise; Laura K Hummers
Journal:  Ann Rheum Dis       Date:  2012-08-11       Impact factor: 19.103

5.  Relation of novel echocardiographic measures to invasive hemodynamic assessment in scleroderma-associated pulmonary arterial hypertension.

Authors:  Deepa M Gopal; Bryan Doldt; Kim Finch; Robert W Simms; Harrison W Farber; Noyan Gokce
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-09       Impact factor: 4.794

6.  Comparison of different measures of diffusing capacity for carbon monoxide (DLCO) in systemic sclerosis.

Authors:  Marie Hudson; Deborah Assayag; Melissa Caron; Benjamin D Fox; Andrew Hirsch; Russell Steele; Rebecca Gaudreau-Taillefer; Solène Tatibouet; Lawrence Rudski; Murray Baron
Journal:  Clin Rheumatol       Date:  2013-06-04       Impact factor: 2.980

Review 7.  Therapeutic Challenges And Advances In The Management Of Systemic Sclerosis-Related Pulmonary Arterial Hypertension (SSc-PAH).

Authors:  Rahul G Argula; Celine Ward; Carol Feghali-Bostwick
Journal:  Ther Clin Risk Manag       Date:  2019-12-13       Impact factor: 2.423

8.  Candidate Genes Identified in Systemic Sclerosis-Related Pulmonary Arterial Hypertension Were Associated with Immunity, Inflammation, and Cytokines.

Authors:  Zhixiao Xu; Jiaxing Ruan; Lingyun Pan; Chengshui Chen
Journal:  Cardiovasc Ther       Date:  2021-02-18       Impact factor: 3.023

Review 9.  Recent Treatments of Interstitial Lung Disease with Systemic Sclerosis.

Authors:  Hidekata Yasuoka
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2016-01-19

10.  End-Stage Kidney Disease From Scleroderma in the United States, 1996 to 2012.

Authors:  Donal J Sexton; Scott Reule; Robert N Foley
Journal:  Kidney Int Rep       Date:  2017-09-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.